Ravi A Madan, Clinical researcher at the National Cancer Institute, shared a paper he and his colleagues published in Dove Medical Press on X:
”Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint Inhibitors.
With new strategies already in the clinic it is time to chart a new path for I/O in Prostate Cancer.”
Title: Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint Inhibitors
Authors: Melissa Abel, Aanika Balaji Warner, Fatima Karzai, Ravi A Madan
Read the Full Article.
You can also read about Immunotherapy for Prostate Cancer on OncoDaily.
